Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction

Abstract Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (ILD), driving its mortality. Specific biomarkers associated with the progression of this lung disease are highly needed. We aimed to identify specific biomarkers of SSc-ILD...

Full description

Bibliographic Details
Main Authors: Julien Guiot, Makon-Sébastien Njock, Béatrice André, Fanny Gester, Monique Henket, Dominique de Seny, Catherine Moermans, Michel G. Malaise, Renaud Louis
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-90333-0

Similar Items

Similar Items